Early Study Finds MGC018 Active in Resistant Skin Cancer

Sekwon Jang, MD in medical oncology at Inova Schar Cancer Institute, presented the latest data on the multi-institutional Phase 1 clinical trial for MGC018 at the annual American Society of Clinical Oncology held June 4–8, 2021. What is MGC018? MGC018 is an investigational drug developed by MacroGenics that is being studied for the treatment of…

Read More

Five Steps to Better Skin Cancer Prevention

Donald J. Brideau, MD, is a board-certified primary care physician with a special interest in dermatology. He practices family medicine at Inova Primary Care – Lorton. Skin is your body’s largest organ. It keeps your other organs safe from the elements and infection while helping to regulate your body temperature. But with all that exposure,…

Read More

Inova Melanoma Symposium Offers Resources and Hope

Sekwon Jang, MD, is board-certified in internal medicine, medical oncology and hematology. He is a member of the Inova Melanoma and Skin Cancer Center, and specializes in the treatment of melanoma and other skin cancers.   We’ve just wrapped up Skin Cancer Awareness Month in May, and the members of the Inova Melanoma and Skin…

Read More

10 Things You Need to Know About Sunscreen

Patricia Lucey, MD, is a board-certified dermatologist at the Inova Melanoma and Skin Cancer Center. She has a special interest in using screenings and other tools to detect the disease at its earliest stages. Read Dr. Lucey’s profile. Skin cancer is the most common of all cancers. Melanoma makes up only a small fraction of skin cancer…

Read More

Raising Skin Cancer Awareness: Inova Dermatologist Joins Skin Cancer Health Fair & Screening on Capitol Hill

Suraj S. Venna, MD, is a board-certified dermatologist and director of the Inova Melanoma and Skin Cancer Center. He has a particular interest in the prevention, detection and treatment of melanoma. Read Dr. Venna’s profile. As a melanoma specialist, I see patients with skin cancer in the clinic every day. Unfortunately, many of those cases…

Read More

Education and Inspiration at Inova’s First Melanoma Patient Symposium

Sekwon Jang, MD, is board certified in medical oncology, hematology and internal medicine. He serves as Inova’s director of Melanoma and Cutaneous Oncology Therapeutics and Research at the Inova Schar Cancer Institute. He has a special interest in melanoma and other skin cancers. Read Dr. Jang’s profile.  On May 21, we held the first-ever Melanoma Patient…

Read More